Yogi Ertanto

Experience

• 2023–present
  Dosen Tetap, Universitas Pertahanan
• 2018–present
  Research Manager, Lembaga Biologi Vaksin
• –present
  Alumni Magister Bioteknologi UGM, Universitas Gadjah Mada
• 2022–2024
  Co-Investigator Clinical Trial, OUCRU-TNI AD

Education

• 2018 
  Universitas Gadjah Mada, Cumlaude

Publications

• 2025
  One-step rapid production of DNA polymerase from Pyrococcus furiosus in Escherichia coli system under optimized culture conditions, https://www.tandfonline.com/doi/abs/10.1080/10826068.2025.2483238
• 2024
  AlphaFold2 artificial intelligence implication to the structure-based drug design and future of integrative structural biology, https://pubs.aip.org/aip/acp/article-abstract/2774/1/020001/3310376/AlphaFold2-artificial-intelligence-implication-to
• 2024
  A molecular docking insight: Phyllanthus niruri L. constituents targeting MMP-9 for angiogenesis inhibition and IL-1β for anti-inflammatory action in endometriosis therapy, https://scholar.unair.ac.id/en/publications/a-molecular-docking-insight-phyllanthus-niruri-l-constituents-tar/
• 2024
  Implementation of a Randomized, Placebo-Controlled Trial of Live Attenuated Malaria Sporozoite Vaccines in an Indonesian Military Study Population (vol 110, pg 892, 2024), https://pmc.ncbi.nlm.nih.gov/articles/PMC11066349/
• 2022
  Anti-Osteoporosis Potencies of Zingiber officinale Rosc. Rhizome Water Extract and DFA III Produced from Dahlia spp. L.: in vivo and in vitro Studies, https://www.inabj.org/index.php/ibj/article/view/1787
• 2019
  Effects of peel extract from Citrus reticulata and hesperidin, a citrus flavonoid, on macrophage cell line., https://www.cabidigitallibrary.org/doi/full/10.5555/20203260988

Professional Memberships

• Ikatan Apoteker Indonesia
• Masyarakat Bioinformatika dan Biodiversitas Indonesia
• Persatuan Biokimia dan Biologi Molekuler Indonesia
• Indonesian Society of Cancer Chemoprevention

Honours

Satyalencana Kesetiaan VIII Tahun, Satyalencana Kesetiaan XVI Tahun